BRPI0601827A - moléculas com atividade antitumoral - Google Patents

moléculas com atividade antitumoral

Info

Publication number
BRPI0601827A
BRPI0601827A BRPI0601827-0A BRPI0601827A BRPI0601827A BR PI0601827 A BRPI0601827 A BR PI0601827A BR PI0601827 A BRPI0601827 A BR PI0601827A BR PI0601827 A BRPI0601827 A BR PI0601827A
Authority
BR
Brazil
Prior art keywords
molecules
antitumor activity
acridine
antitumor
activity
Prior art date
Application number
BRPI0601827-0A
Other languages
English (en)
Inventor
Ivan Da Rocha Pitta
Suely Lins Galdino
Maria Do Carmo Alves De Lima
Original Assignee
Univ Fed Pernambuco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Fed Pernambuco filed Critical Univ Fed Pernambuco
Priority to BRPI0601827-0A priority Critical patent/BRPI0601827A/pt
Priority to EP07719242A priority patent/EP2004628A2/en
Priority to PCT/BR2007/000074 priority patent/WO2007109871A2/en
Publication of BRPI0601827A publication Critical patent/BRPI0601827A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

MOLéCULAS COM ATIVIDADE ANTITUMORAL. Síntese de novos compostos acridino-tiazolidínicos e acridino-imidaziolidínico com atividade antitumoral e seu uso terapêutico como drogas antitumorais.
BRPI0601827-0A 2006-03-24 2006-03-24 moléculas com atividade antitumoral BRPI0601827A (pt)

Priority Applications (3)

Application Number Priority Date Filing Date Title
BRPI0601827-0A BRPI0601827A (pt) 2006-03-24 2006-03-24 moléculas com atividade antitumoral
EP07719242A EP2004628A2 (en) 2006-03-24 2007-03-23 Acridine derivatives with antitumoral activity
PCT/BR2007/000074 WO2007109871A2 (en) 2006-03-24 2007-03-23 Acridine derivatives with antitumoral activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0601827-0A BRPI0601827A (pt) 2006-03-24 2006-03-24 moléculas com atividade antitumoral

Publications (1)

Publication Number Publication Date
BRPI0601827A true BRPI0601827A (pt) 2007-11-27

Family

ID=38541452

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0601827-0A BRPI0601827A (pt) 2006-03-24 2006-03-24 moléculas com atividade antitumoral

Country Status (3)

Country Link
EP (1) EP2004628A2 (pt)
BR (1) BRPI0601827A (pt)
WO (1) WO2007109871A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1101273B1 (pt) * 2011-03-10 2022-07-19 Universidade Federal De Pernambuco Moléculas imidazolidínicas e tiazoldínicas com atividades anti-t.cruzi
WO2013053034A2 (pt) * 2011-10-10 2013-04-18 Universidade Federal De Pernambuco - Ufpe Tiazacridinas utilizadas na terapia anticâncer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0203747A (pt) * 2002-09-10 2004-05-25 Conselho Nacional Cnpq Moléculas com atividade antitumoral e processo para a sua obtenção

Also Published As

Publication number Publication date
WO2007109871A3 (en) 2009-06-11
EP2004628A2 (en) 2008-12-24
WO2007109871A2 (en) 2007-10-04

Similar Documents

Publication Publication Date Title
CY1118061T1 (el) Δικυκλικα παραγωγα heterocyclyl σαν καταστολεις κινασης (kinase) fgfr για θεραπευτικη χρηση
CY1121646T1 (el) Παραγωγα μορφινανης για την αγωγη υπερβολικης δοσης ναρκωτικων
DOP2009000196A (es) Inhibidores de la actividad de akt
CU20120042A7 (es) (heteroarilmetil)tiohidantoínas sustituidas como drogas anticáncer
GB2471588A (en) Therapeutic peptidomimetic macrocycles
CL2011003346A1 (es) Compuestos derivados de 2,3-dihidro-5h-[1,3]tiazolo[3,2-a]pirimidin-5-ona, moduladores de pi3k; composicion farmaceutica; y uso para tratar una enfermedad de base inmunologica, cancer o enfermedad pulmonar en un paciente.
CR20120510A (es) Derivados de piperidin-4-il azetidina como inhibidores de jak1
DK1951729T3 (da) Oxygenbundne pyrimidinderivater
TR201900259T4 (tr) Heterosiklik Bileşikler Ve Bunların Kullanımları
EA201100450A1 (ru) Макроциклические пирамидины в качестве ингибиторов протеинкиназы
BRPI0717266A2 (pt) Derivados de oxindol
TW200745109A (en) Pyrrolo-pyridine kinase modulators
ATE502038T1 (de) Azyklische amininhibitoren von nukleosidphosphorylasen und hydrolasen
UY31952A (es) 5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim
BR112013003248A2 (pt) "macrociclo peptidomimético e seus usos"
BRPI0614397A2 (pt) compostos de pirimidina como moduladores de receptor de serotonina
CL2011000119A1 (es) Compuestos derivados de triazolo[4,3-a]piridina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer.
DE602006016231D1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl-y-aminopropyl-azalide mit antimalaria-aktivität
UY32190A (es) Derivados de anilina-pirimidina sustituidos con sulfoximina como inhibdores de quinasas dependientes de ciclina (cdk), produccion y uso de los mismos como productos medicinales
UY31016A1 (es) Nuevos compuestos heterociclicos nitrogenados, su preparacion y su utilizacion como medicamentos antibacterianos
CL2008000495A1 (es) Compuestos derivados de tetrahidro-pirazolo[4,3-c]piridina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como alergias, inflamacion, dolor, cancer, entreotras.
MA31630B1 (fr) Dérivés de 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamides et de 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamides, leur préparation et leur application en thérapeutique
ECSP088176A (es) Derivados de azinil-3-sulfonilindazol como ligandos de5-hidroxitriptamina-6
BRPI0601827A (pt) moléculas com atividade antitumoral
UY31646A1 (es) Uso de fenilimidazolidinas sustituidas para producir medicamentos para el tratamiento del síndrome metabólico

Legal Events

Date Code Title Description
B08E Application fees: payment of additional fee required [chapter 8.5 patent gazette]

Free format text: COMPLEMENTAR 9A ANUIDADE, DE ACORDO COM TABELA VIGENTE, REFERENTE A GUIA 221401981792 E COMPROVAR TAXA DE RESTAURACAO REFERENTE A 10A ANUIDADE.

B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B08H Application fees: decision cancelled [chapter 8.8 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08G Application fees: restoration [chapter 8.7 patent gazette]
B04C Request for examination: application reinstated [chapter 4.3 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 14A ANUIDADE

B08G Application fees: restoration [chapter 8.7 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06V Preliminary requirement: patent application procedure suspended [chapter 6.22 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]